The highly customized nature of cell and gene therapy production means that manufacturing innovations for one therapy may not be easily transferable to others.
Pascale Diesel
Advertisement
Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.
Articles by Pascale Diesel
Equipment and Processing Report
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement